374 related articles for article (PubMed ID: 25162124)
1. Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning.
Janero DR
Expert Opin Drug Discov; 2014 Nov; 9(11):1265-79. PubMed ID: 25162124
[TBL] [Abstract][Full Text] [Related]
2. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
Janero DR
Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
[TBL] [Abstract][Full Text] [Related]
3. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
4. Can open-source drug R&D repower pharmaceutical innovation?
Munos B
Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
[TBL] [Abstract][Full Text] [Related]
5. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 2. Pharma's challenges and their commitment to innovation.
Abou-Gharbia M; Childers WE
J Med Chem; 2014 Jul; 57(13):5525-53. PubMed ID: 24428137
[TBL] [Abstract][Full Text] [Related]
6. A Pressing Need for Pharmacotherapy Development to Treat Drug Addiction: An Editorial from a Legal Perspective.
Andraka-Christou B
Int Rev Neurobiol; 2016; 126():15-38. PubMed ID: 27055610
[TBL] [Abstract][Full Text] [Related]
7. Discontinued drugs in 2010: oncology drugs.
Williams R
Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
[TBL] [Abstract][Full Text] [Related]
8. Is pharma running out of brainy ideas?
Miller G
Science; 2010 Jul; 329(5991):502-4. PubMed ID: 20671165
[No Abstract] [Full Text] [Related]
9. [Biomarkers: "Found in translation"].
Lockhart BP; Walther B
Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
[TBL] [Abstract][Full Text] [Related]
10. Partnerships in Pharma--An Economist Intelligence Unit Seminar--Building Innovation into Alliances and Business Models. 1 October 2010, London, UK.
Kibble A
IDrugs; 2010 Dec; 13(12):813-5. PubMed ID: 21154130
[TBL] [Abstract][Full Text] [Related]
11. How academic labs can approach the drug discovery process as a way to synergize with big pharma.
Loregian A; Palù G
Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493
[TBL] [Abstract][Full Text] [Related]
12. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
13. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 1. Criticisms faced by the pharmaceutical industry.
Abou-Gharbia M; Childers WE
J Med Chem; 2013 Jul; 56(14):5659-72. PubMed ID: 23557017
[TBL] [Abstract][Full Text] [Related]
14. Why and how have drug discovery strategies in pharma changed? What are the new mindsets?
Mignani S; Huber S; Tomás H; Rodrigues J; Majoral JP
Drug Discov Today; 2016 Feb; 21(2):239-49. PubMed ID: 26376356
[TBL] [Abstract][Full Text] [Related]
15. Accessing external innovation in drug discovery and development.
Tufféry P
Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
[TBL] [Abstract][Full Text] [Related]
16. Drug discovery in pharmaceutical industry: productivity challenges and trends.
Khanna I
Drug Discov Today; 2012 Oct; 17(19-20):1088-102. PubMed ID: 22627006
[TBL] [Abstract][Full Text] [Related]
17. Brazil: An emerging partner in drug R&D.
Rodrigues DG
IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
[TBL] [Abstract][Full Text] [Related]
18. Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care.
Phillips AG; Hongaard-Andersen P; Moscicki RA; Sahakian B; Quirion R; Krishnan KR; Race T
Int J Neuropsychopharmacol; 2014 Dec; 18(3):. PubMed ID: 25542690
[TBL] [Abstract][Full Text] [Related]
19. Leveraging crowdsourcing to facilitate the discovery of new medicines.
Norman TC; Bountra C; Edwards AM; Yamamoto KR; Friend SH
Sci Transl Med; 2011 Jun; 3(88):88mr1. PubMed ID: 21697527
[TBL] [Abstract][Full Text] [Related]
20. Translational research in addiction: toward a framework for the development of novel therapeutics.
Paterson NE
Biochem Pharmacol; 2011 Jun; 81(12):1388-407. PubMed ID: 21216239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
